QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026)

QuidelOrtho's (QDEL) quarterly Cash from Financing Activities came in at $37.6 million in Q1 2026, up 113.64% year-on-year from $17.6 million in Q1 2025, and up 438.74% quarter-over-quarter from -$11.1 million in Q4 2025.

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

QuidelOrtho has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $37.6 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $37.6 million, up 113.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $175.8 million (up 107.07% YoY), and the FY2025 annual result was $155.8 million, up 219.26% from the prior year.
  • Cash from Financing Activities came in at $37.6 million for Q1 2026 at QuidelOrtho, up from -$11.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $424.2 million in Q1 2023 to a low of -$99.7 million in Q3 2023.
  • The 5-year median for Cash from Financing Activities is -$11.1 million (2025), against an average of $26.5 million.
  • Across the five-year window, Cash from Financing Activities slumped 1652.94% in 2023 and jumped 274.9% in 2025, its largest moves.
  • QuidelOrtho's Cash from Financing Activities stood at -$3.4 million in 2022, then sank by 1600.0% to -$57.8 million in 2023, then retreated by 19.2% to -$68.9 million in 2024, then surged by 83.89% to -$11.1 million in 2025, then soared by 438.74% to $37.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at $37.6 million (Q1 2026), -$11.1 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 QuidelOrtho 934.34 Mn 793.94 Mn - 37.60 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 37.60 Mn
Mar 29, 2026 37.60 Mn
Dec 28, 2025 -11.10 Mn
Dec 28, 2025 -11.10 Mn
Sep 28, 2025 46.00 Mn
Sep 28, 2025 46.00 Mn
Jun 29, 2025 103.30 Mn
Jun 29, 2025 103.30 Mn
Mar 30, 2025 17.60 Mn
Mar 30, 2025 17.60 Mn
Dec 29, 2024 -68.90 Mn
Dec 29, 2024 -68.90 Mn
Sep 29, 2024 -26.30 Mn
Sep 29, 2024 -26.30 Mn
Jun 30, 2024 162.50 Mn
Jun 30, 2024 162.50 Mn
Mar 31, 2024 -18.50 Mn
Mar 31, 2024 -18.50 Mn
Dec 31, 2023 -57.80 Mn
Dec 31, 2023 -57.80 Mn